What is Shattuck Labs, Inc. (STTK) stock price today?

Shattuck Labs, Inc. (STTK) is currently trading at $5.97, up 5.48% today.

What is STTK P/E ratio?

Shattuck Labs, Inc.'s P/E ratio is -13.20. This is below the market average, suggesting the stock may be undervalued relative to earnings.

What is STTK return on equity (ROE)?

Shattuck Labs, Inc.'s return on equity (ROE) is -43.57%, indicating how efficiently the company generates profit from shareholders' equity. This is below the typical market average of 12-15%.

What is Shattuck Labs, Inc.'s market cap?

Shattuck Labs, Inc. has a market capitalization of $539.52M.

NMS · Biotechnology

Shattuck Labs, Inc. (STTK) Stock

$5.97 +5.48% NMS: STTK Healthcare

Valuation

Metric	Value
Price	$5.97
Market Cap	$539.52M
P/E Ratio	-13.20
P/B Ratio	4.14
P/S Ratio	608.21
EPS (TTM)	$-0.70
52-Week High	$8.33
52-Week Low	$1.70
Dividend Yield	0.00%

Financials & Margins

Metric	Value
ROE	-43.57%
ROA	-23.82%
ROCE	-26.20%
Gross Margin	-5200.00%
Operating Margin	-5200.00%
Net Margin	-49.87%
Debt/Equity	0.01
Current Ratio	11.71

Annual Financials (USD)

Metric	2021	2022	2023	2024	2025
Revenue	$30.0M	$1.0M	$2.0M	$6.0M	$1.0M
Operating Profit	$-45.0M	$-103.0M	$-92.0M	$-81.0M	$-52.0M
Net Profit	$-45.0M	$-102.0M	$-87.0M	$-75.0M	$-49.0M
EPS	$-1.07	$-2.41	$-2.05	$-1.49	$-0.70
Op Margin	-150.8%	-15848.0%	-5549.6%	-1408.3%	-5150.8%

Balance Sheet (USD)

Metric	2021	2022	2023	2024	2025
Total Assets	$299.0M	$205.0M	$160.0M	$91.0M	$91.0M
Total Liabilities	$27.0M	$29.0M	$15.0M	$11.0M	$9.0M
Cash	$92.0M	$47.0M	$126.0M	$57.0M	$54.0M
Borrowings	$0	$5.0M	$4.0M	$3.0M	$2.0M

Latest News

Netflix upgraded, Microsoft initiated: Wall Street's top analyst calls The Fly · Jul 20, 2026 Shattuck Labs Prices $75 Million Public Offering MT Newswires · Jun 10, 2026 Shattuck Labs, Inc. Announces Pricing of $75 Million Public Offering GlobeNewswire · Jun 10, 2026 Shattuck Labs Launches Public Offering of Common Stock MT Newswires · Jun 9, 2026 Shattuck Labs, Inc. Announces Proposed Public Offering GlobeNewswire · Jun 9, 2026

Cash Flow (USD)

Metric	2021	2022	2023	2024	2025
Operating Cash Flow	$-57.0M	$-94.0M	$-81.0M	$-61.0M	$-40.0M
Investing Cash Flow	$-18.0M	$38.0M	$110.0M	$-9.0M	$-8.0M
Financing Cash Flow	$0	$0	$0	$1.0M	$0
Net Cash Flow	$-66.0M	$-45.0M	$78.0M	$-68.0M	$-3.0M
Free Cash Flow	$-65.0M	$-106.0M	$-82.0M	$-61.0M	$-40.0M

Valuation & Return Ratios

Metric	Value
PEG Ratio	-0.13
EV / EBITDA	-11.30
FCF Yield	-6.78%
Quick Ratio	27.59
Interest Coverage	0.00
Return 1Y	764.63%
Return 3Y	167.55%
Return 5Y	-71.86%

Ownership

Insiders Held4.53%

Institutions Held60.05%

Institutions Float Held62.90%

Institutional Holder	Shares	Report Date
T. Rowe Price Investment Management, Inc.	9,865,558	2026-03-31
Orbimed Advisors LLC.	6,306,127	2026-03-31
Redmile Group, LLC	5,539,724	2026-03-31
Prosight Management, Lp	5,004,439	2026-03-31
Adage Capital Partners GP L.L.C.	4,644,957	2026-03-31

Peer Comparison

Ticker	Price	Change	P/E	Market Cap	Div Yield
BDTXBlack Diamond Therapeutics, Inc.	$1.83	+1.10%	-2.62	$104.86M	0.00%
CBIOCrescent Biopharma, Inc.	$14.91	+5.59%	-1.84	$553.82M	0.00%
CVMCel-Sci Corporation	$1.94	-0.51%	-0.90	$13.33M	0.00%
FTHFaeth Therapeutics, Inc.	$26.03	+1.64%	-0.19	$671.02M	0.00%
INDPIndaptus Therapeutics, Inc.	$2.51	+5.91%	-0.34	$284.24M	0.00%

About Shattuck Labs, Inc.

Shattuck Labs, Inc. is led by CEO Taylor H. Schreiber, employs 44 people, headquartered in US, publicly traded since 2020.

Shattuck Labs, Inc. (STTK) stock trades at $5.97 with a market capitalization of $539.52M. The stock is valued at a price-to-earnings (P/E) ratio of -13.20, price-to-book of 4.14, price-to-sales of 608.21. Over the past 52 weeks the stock has ranged between $1.70 and $8.33, and currently trades 28.3% below its 52-week high.

On profitability, Shattuck Labs, Inc. generates a return on equity (ROE) of -43.57%, return on capital employed of -26.20%, an operating margin of -5200.00%, a net profit margin of -49.87%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Screens featuring this stock

High ROE Healthcare Stocks Low P/E Healthcare Stocks High Net Margin Healthcare Stocks Dividend Healthcare Stocks Low Debt Healthcare Stocks All stock screens

Run Stock Screener Investing Guides